Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04776655
Title Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB (LIBImAb)
Acronym LIBImAb
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Azienda Unita Sanitaria Locale Reggio Emilia
Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST